Reaktion #2446111
ord-ae1e1b1119c54cfaa846259f4c90670c
Reaktionsgleichung
Edukte
Reagenzien
Reaktionsbedingungen
Aufarbeitung
- 1Sonstigein dry
- 2Sonstigedegassed tetrahydrofuran (120 mL)
- 3workup.STIRRINGThe mixture was stirred at −5° C. for 30 min
- 4workup.STIRRINGThe reaction was stirred at room temperature for 2 h
- 5EinengenThe mixture was concentrated under vacuum to half of its initial volume
- 6workup.ADDITIONEtOAc (50 mL) was added
- 7Sonstigelayers were separated
- 8WaschenThe organic phase was further washed with water (3×20 mL) and brine (40 mL)
- 9Einengenwas concentrated
- 10SonstigeThe residue was purified by silica gel chromatography
- 11Sonstigeto afford a white foam in 55% yield (7.0 g, 13.4 mmol)
- 12workup.STIRRINGstirred for 1 h
- 13EinengenThe solution was then concentrated under vacuum
Vorschrift
Oxycodone free base (6.5 g, 20.6 mmol) was dissolved in dry, degassed tetrahydrofuran (120 mL), and the mixture was cooled to −10° C. using a dry ice/acetone bath. Potassium bis(trimethylsilyl)amide (KHMDS) (103.0 mL, 51.6 mmol, 0.5 M in toluene) was added via cannula. The mixture was stirred under N2 at below −5° C. for 30 min. N,N-Bis(tert-butyl) N′-2-(chlorocarbonyl(methyl)amino)ethylcarbamate (8.0 g, 23.7 mmol), (Compound C) in THF (30 mL) was then added via cannula over 15 min. The mixture was stirred at −5° C. for 30 min. Another portion of carbamoyl chloride (4.0 g, 11.9 mmol) in THF (10 mL) was added. The reaction was stirred at room temperature for 2 h. Sodium bicarbonate (10 mL, sat. aq.) was added. The mixture was concentrated under vacuum to half of its initial volume. EtOAc (50 mL) was added, and layers were separated. The organic phase was further washed with water (3×20 mL) and brine (40 mL), and then was concentrated. The residue was purified by silica gel chromatography, using DCM/MeOH (gradient 100/1 to 100/15) to afford a white foam in 55% yield (7.0 g, 13.4 mmol). This material was dissolved in a 1:1 mixture of DCM/trifluoroacetic acid (TFA) (20 mL/20 mL) at room temperature and stirred for 1 h. The solution was then concentrated under vacuum to afford a TFA salt of oxycodone 6-(N-methyl-N-(2-amino)ethylcarbamate (Compound KC-19) as a thick oil (7.3 g, 11.4 mmol, 99% purity). MS: (m/z) calc: 415.2, observed (M+H+) 416.5.